1-( O-acetyl)-hadiensine
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | IsyOlx7jt3b |
|---|---|
| InChI | InChI=1S/C20H29NO7/c1-5-14-10-12(2)19(4,25)18(24)26-11-20(28-13(3)22)7-9-21-8-6-15(16(20)21)27-17(14)23/h5,12,15-16,25H,6-11H2,1-4H3/b14-5-/t12-,15+,16-,19+,20-/m0/s1 |
| InChIKey | ZSDXFSCOUYFASR-ANJMPXDESA-N |
| Mol Weight | 395.45 g/mol |
| Molecular Formula | C20H29NO7 |
| Exact Mass | 395.194402 g/mol |
| Enantiomer InChIKey | ZSDXFSCOUYFASR-OZKAKJOPSA-N |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | X2-54-498-11 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2,12-bis(O-acetyl)-rosmarinine
ethyl 6-{[[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methyl](methyl)amino]methyl}-4-[4-methoxy-3-(methoxymethyl)phenyl]-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
ANGULARINE-N-0XIDE
Floridaline - propionate
(1R * ,1'R * ,5S * )-2-(methoxymethoxy)-2'-oxospiro[bicyclo[3.1.0]hex-2-ene-6,1'-cyclododecane]-3-carboxylate
#16;MAJOR;(1'R,2'S,3'S,5S)-2-[1'-(TERT.-BUTYLOXYCARBONYLOXY)-4'-HYDROXY-2',3'-BIS-METHOXYMETHOXY]-BUTYL-3,3-DIMETHOXY-PYRROLIDINE-1-CARBOXYLIC-ACID-TERT.-BUTYL
Benzyl rac-(2S,3aR,4S,7aS)-4-acetyl-2-(furan-2-yl)-2,3,3a,4,5,7ahexahydro-1H-indole-1-carboxylate
(6Z)-6-({1-[3-(2,3-dimethylphenoxy)propyl]-1H-indol-3-yl}methylene)-5-imino-2-methyl-5,6-dihydro-7H-[1,3]thiazolo[3,2-a]pyrimidin-7-one
Dinosterol
2,2-Spirotetramethylene-3-(2'-phenylsulphonylethyl)-7-methyl-3,7-diaza-4-oxabicyclo[3.3.0]octane-6,8-dione
| Title | Journal or Book | Year |
|---|---|---|
| Pyrrolizidine Alkaloids from Senecio hadiensis | Journal of Natural Products | 1991 |
This compound is available in the following databases:
Wiley Registry of Mass Spectral Data 2023
Author: Wiley
The foundation library for any analytical laboratory running mass spectrometry, the Wiley Registry provides the broadest coverage available in any mass spectral library Learn more.